Lancet 2006 Sep 2
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Related Questions
Especially in patients who are not candidates for chemotherapy, what dose and fractionation should be applied given the fact that hyperfractionation w...
New comment by Radiation Oncologist at University of Michigan ( February 21, 2017)
I don’t think it was published but this is what I do. There is no reason to treat sub-clinical disease BID. The DAHANCA used 2D and treated BID everything, but with IMRT, tr...